Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Association of Medicaid Expansion With Health Insurance Coverage Among Persons With a Disability.

Stimpson JP, Kemmick Pintor J, McKenna RM, Park S, Wilson FA.

JAMA Netw Open. 2019 Jul 3;2(7):e197136. doi: 10.1001/jamanetworkopen.2019.7136.

2.

Insurance-Based Disparities In Access, Utilization, And Financial Strain For Adults With Psychological Distress.

McKenna RM, Pintor JK, Ali MM.

Health Aff (Millwood). 2019 May;38(5):826-834. doi: 10.1377/hlthaff.2018.05237.

PMID:
31059361
3.

Racial and Ethnic Disparities in Provider-Related Barriers to Health Care for Children in California After the ACA.

Alberto CK, Kemmick Pintor J, McKenna RM, Roby DH, Ortega AN.

Glob Pediatr Health. 2019 Feb 10;6:2333794X19828356. doi: 10.1177/2333794X19828356. eCollection 2019.

4.

Examining EMTALA in the era of the patient protection and Affordable Care Act.

McKenna RM, Purtle J, Nelson KL, Roby DH, Regenstein M, Ortega AN.

AIMS Public Health. 2018 Oct 8;5(4):366-377. doi: 10.3934/publichealth.2018.4.366. eCollection 2018.

5.

The Affordable Care Act and Trends in Insurance Coverage and Disease Awareness Among Non-elderly Individuals with Kidney Disease.

Harhay MN, McKenna RM.

J Gen Intern Med. 2019 Mar;34(3):351-353. doi: 10.1007/s11606-018-4713-2. No abstract available.

PMID:
30367328
6.

Insurance Coverage and Utilization Improve for Latino Youth but Disparities by Heritage Group Persist Following the ACA.

Kemmick Pintor J, Chen J, Alcalá HE, Langellier BA, McKenna RM, Roby DH, Ortega AN.

Med Care. 2018 Nov;56(11):927-933. doi: 10.1097/MLR.0000000000000992.

PMID:
30234767
7.

Disparities in Pediatric Provider Availability by Insurance Type After the ACA in California.

Kemmick Pintor J, Alcalá HE, Roby DH, Grande DT, Alberto CK, McKenna RM, Ortega AN.

Acad Pediatr. 2019 Apr;19(3):325-332. doi: 10.1016/j.acap.2018.09.003. Epub 2018 Sep 12.

PMID:
30218840
8.

Health Care Access and Physical and Behavioral Health Among Undocumented Latinos in California.

Ortega AN, McKenna RM, Kemmick Pintor J, Langellier BA, Roby DH, Pourat N, Vargas Bustamante A, Wallace SP.

Med Care. 2018 Nov;56(11):919-926. doi: 10.1097/MLR.0000000000000985.

9.

Access-To-Care Differences Between Mexican-Heritage And Other Latinos In California After The Affordable Care Act.

Bustamante AV, McKenna RM, Viana J, Ortega AN, Chen J.

Health Aff (Millwood). 2018 Sep;37(9):1400-1408. doi: 10.1377/hlthaff.2018.0416.

PMID:
30179559
10.

The Affordable Care Act Attenuates Financial Strain According to Poverty Level.

McKenna RM, Langellier BA, Alcalá HE, Roby DH, Grande DT, Ortega AN.

Inquiry. 2018 Jan-Dec;55:46958018790164. doi: 10.1177/0046958018790164.

11.

Association between Medicaid Expansion under the Affordable Care Act and Preemptive Listings for Kidney Transplantation.

Harhay MN, McKenna RM, Boyle SM, Ranganna K, Mizrahi LL, Guy S, Malat GE, Xiao G, Reich DJ, Harhay MO.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1069-1078. doi: 10.2215/CJN.00100118. Epub 2018 Jun 21.

12.

Health Care Access and Utilization Among U.S. Immigrants Before and After the Affordable Care Act.

Bustamante AV, Chen J, McKenna RM, Ortega AN.

J Immigr Minor Health. 2019 Apr;21(2):211-218. doi: 10.1007/s10903-018-0741-6.

PMID:
29633069
13.

Insurance Type and Access to Health Care Providers and Appointments Under the Affordable Care Act.

Alcalá HE, Roby DH, Grande DT, McKenna RM, Ortega AN.

Med Care. 2018 Feb;56(2):186-192. doi: 10.1097/MLR.0000000000000855.

PMID:
29271819
14.

Treatment use, sources of payment, and financial barriers to treatment among individuals with opioid use disorder following the national implementation of the ACA.

McKenna RM.

Drug Alcohol Depend. 2017 Oct 1;179:87-92. doi: 10.1016/j.drugalcdep.2017.06.028. Epub 2017 Jul 24.

PMID:
28763780
15.

Insurance Coverage and Well-Child Visits Improved for Youth Under the Affordable Care Act, but Latino Youth Still Lag Behind.

Ortega AN, McKenna RM, Chen J, Alcalá HE, Langellier BA, Roby DH.

Acad Pediatr. 2018 Jan - Feb;18(1):35-42. doi: 10.1016/j.acap.2017.07.006. Epub 2017 Jul 21.

PMID:
28739534
16.

The Affordable Care Act Reduces Hypertension Treatment Disparities for Mexican-heritage Latinos.

McKenna RM, Alcalá HE, Lê-Scherban F, Roby DH, Ortega AN.

Med Care. 2017 Jul;55(7):654-660. doi: 10.1097/MLR.0000000000000726.

PMID:
28614177
17.

Experiences in Care According to Parental Citizenship and Language Use Among Latino Children in California.

Ortega AN, McKenna RM, Langellier BA, Alcalá HE, Roby DH.

Acad Pediatr. 2018 Jan - Feb;18(1):20-25. doi: 10.1016/j.acap.2016.12.017. Epub 2017 Jan 5.

PMID:
28065799
18.

Current practice in bowel preparation for colorectal surgery: a survey of the members of the Association of Coloproctology of GB & Ireland.

Drummond RJ, McKenna RM, Wright DM.

Colorectal Dis. 2011 Jun;13(6):708-10. doi: 10.1111/j.1463-1318.2010.02243.x. Epub 2010 Feb 20.

PMID:
20184637
19.

Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection.

Grimm PC, Nickerson P, Jeffery J, Savani RC, Gough J, McKenna RM, Stern E, Rush DN.

N Engl J Med. 2001 Jul 12;345(2):93-7.

20.

Increased levels of GALbeta1-4GLCNACalpha2-6 sialyltransferase pretransplant predict delayed graft function in kidney transplant recipients.

Thorne-Tjomsland G, Hosfield T, Jamieson JC, Liu B, Nickerson P, Gough JC, Rush DN, Jeffery JR, McKenna RM.

Transplantation. 2000 Mar 15;69(5):806-8.

PMID:
10755530
21.

Improving HLA matching for kidney transplantation by use of CREGs.

McKenna RM, Takemoto SK.

Lancet. 2000 May 27;355(9218):1842-3. No abstract available.

PMID:
10866435
22.

Anti-HLA antibodies after solid organ transplantation.

McKenna RM, Takemoto SK, Terasaki PI.

Transplantation. 2000 Feb 15;69(3):319-26. Review.

PMID:
10706035
23.

Immune-activation gene expression in clinically stable renal allograft biopsies: molecular evidence for subclinical rejection.

Lipman ML, Shen Y, Jeffery JR, Gough J, McKenna RM, Grimm PC, Rush DN.

Transplantation. 1998 Dec 27;66(12):1673-81.

PMID:
9884258
24.

Protocol biopsies in renal transplantation: research tool or clinically useful?

Rush DN, Nickerson P, Jeffery JR, McKenna RM, Grimm PC, Gough J.

Curr Opin Nephrol Hypertens. 1998 Nov;7(6):691-4. Review.

PMID:
9864667
25.

Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function.

McKenna RM, Lee KR, Gough JC, Jeffery JR, Grimm PC, Rush DN, Nickerson P.

Transplantation. 1998 Jul 15;66(1):38-43.

PMID:
9679819
26.

Antibodies to interferon-alpha in treated cancer patients: incidence and significance.

McKenna RM, Oberg KE.

J Interferon Cytokine Res. 1997 Mar;17(3):141-3. Review.

PMID:
9085938
27.

Low frequency of infiltrating cells intensely expressing T cell cytokine mRNA in human renal allograft rejection.

Grimm PC, McKenna RM, Gospodarek EM, Jeffery JR, Rush DN.

Transplantation. 1995 Feb 27;59(4):579-84.

PMID:
7533348
28.

High serum levels of interleukin-6 in renal transplant recipients with monoclonal gammopathies.

Nickerson PW, Rush DN, Jeffery JR, Pochinco D, McKenna RM.

Transplantation. 1994 Aug 15;58(3):382-6. No abstract available.

PMID:
8053065
29.

Increased production of tumor necrosis factor activity by hemodialysis but not peritoneal dialysis patients.

McKenna RM, Macdonald C, Bernstein KN, Rush DN.

Nephron. 1994;67(2):190-6.

PMID:
8072608
30.

Production of tumor necrosis factor alpha and hemodialysis.

Macdonald C, Rush DN, Bernstein KN, McKenna RM.

Nephron. 1993;65(2):273-7.

PMID:
8247192
31.

A multicenter study to evaluate a novel assay for quantitation of soluble interleukin 2 receptor in renal transplant recipients.

Schroeder TJ, Helling T, McKenna RM, Rush D, Jeffrey JR, Brewer B, Martin LA, Traylor D, Fisher RA, First MR, et al.

Transplantation. 1992 Jan;53(1):34-40.

PMID:
1733082
32.

Immunological monitoring in cyclosporine-treated patients.

McKenna RM, Schroeder TJ.

Clin Biochem. 1991 Feb;24(1):75-80. Review.

PMID:
2060136
33.

Postgraduate experience--the great sex divide in health sciences.

McKenna RM, Richmond KA, Dodd JG, Chow DA.

N Engl J Med. 1990 Dec 6;323(23):1637-8. No abstract available.

PMID:
2233959
35.

Cyclosporin A and G inhibition of cytokine production.

Szturm K, Jeffery JR, Rush DN, McKenna RM.

Transplant Proc. 1989 Feb;21(1 Pt 1):857. No abstract available.

PMID:
2705251
36.

The effect of a pretransplant blood transfusion on lymphokine production in patients with renal failure.

McKenna RM, Bakkestad-Legare P, Rush DN, Jeffery JR.

Transplant Proc. 1989 Feb;21(1 Pt 2):1827. No abstract available.

PMID:
2496495
37.

Inhibition of cytokine production by cyclosporine A and G.

McKenna RM, Szturm K, Jeffery JR, Rush DN.

Transplantation. 1989 Feb;47(2):343-8.

PMID:
2493179
38.

Lymphokine production in cyclosporine-treated renal transplant recipients.

McKenna RM, Rush DN, Bakkestad-Legare P, Jeffrey JR.

Transplant Proc. 1988 Dec;20(6):1245-7. No abstract available.

PMID:
3144073
39.

Functional T cells in human renal allograft fine-needle aspirates.

McKenna RM, Heiman D, Rush DN, Jeffrey JR.

Transplant Proc. 1988 Dec;20(6):1237-8. No abstract available.

PMID:
3059612
40.

Catalase increases lymphocyte proliferation in mixed lymphocyte culture.

Rush DN, McKenna RM, Walker SM, Bakkestad-Legare P, Jeffrey JR.

Transplant Proc. 1988 Dec;20(6):1271-3. No abstract available.

PMID:
2974206
41.

Lymphokine production in rheumatoid arthritis and systemic lupus erythematosus.

McKenna RM, Wilkins JA, Warrington RJ.

J Rheumatol. 1988 Nov;15(11):1639-42.

PMID:
3148712
42.

Limiting dilution analysis of the frequency of functional T cells in human renal allograft fine needle aspirates.

McKenna RM, Heiman D, Rush DN, Jeffery JR.

Transplant Proc. 1988 Apr;20(2):207-8. No abstract available.

PMID:
3129831
43.

Interleukin 2, interferon, and lymphotoxin in renal transplant recipients.

McKenna RM, Rush DN, Bakkestad-Legare P, Jeffery JR.

Transplantation. 1988 Jan;45(1):76-81.

PMID:
3122387
44.
45.

Interleukin 2 production and responsiveness in active and inactive rheumatoid arthritis.

McKenna RM, Ofosu-Appiah W, Warrington RJ, Wilkins JA.

J Rheumatol. 1986 Feb;13(1):28-32.

PMID:
3486288
46.
47.

The suppression of experimental allergic encephalomyelitis in Lewis rats by treatment with myelin basic protein-cell conjugates.

McKenna RM, Carter BG, Paterson JA, Sehon AH.

Cell Immunol. 1983 Oct 15;81(2):391-402.

PMID:
6196127
48.

Allergy to tattooing.

McKENNA RM.

Practitioner. 1948 Jun;160(960):471. No abstract available.

PMID:
18860850

Supplemental Content

Loading ...
Support Center